Ondine Biomedical Management
Management criteria checks 1/4
Ondine Biomedical's CEO is Carolyn Cross, appointed in Feb 2005, has a tenure of 19.83 years. directly owns 39.48% of the company’s shares, worth £8.48M. The average tenure of the management team and the board of directors is 1.9 years and 6.8 years respectively.
Key information
Carolyn Cross
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 19.8yrs |
CEO ownership | 39.5% |
Management average tenure | 1.9yrs |
Board average tenure | 6.8yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -CA$14m |
Mar 31 2024 | n/a | n/a | -CA$14m |
Dec 31 2023 | n/a | n/a | -CA$14m |
Sep 30 2023 | n/a | n/a | -CA$17m |
Jun 30 2023 | n/a | n/a | -CA$19m |
Mar 31 2023 | n/a | n/a | -CA$19m |
Dec 31 2022 | CA$892k | CA$476k | -CA$19m |
Sep 30 2022 | n/a | n/a | -CA$37m |
Jun 30 2022 | n/a | n/a | -CA$54m |
Mar 31 2022 | n/a | n/a | -CA$52m |
Dec 31 2021 | CA$699k | n/a | -CA$50m |
Compensation vs Market: Insufficient data to establish whether Carolyn's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: Carolyn's compensation has increased whilst the company is unprofitable.
CEO
Carolyn Cross
19.8yrs
Tenure
CA$892,116
Compensation
Ms. Carolyn M. Cross, C.F.A. & M.B.A., has been Chairman and Chief Executive Officer of Sinuwave Technologies Corporation since 2011. She is founder of Ondine Biomedical Inc. and had been its Chairman sinc...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 19.8yrs | CA$892.12k | 39.48% £ 8.5m | |
President | 20.7yrs | CA$1.16m | 1.03% £ 221.0k | |
Interim Chief Financial Officer | less than a year | no data | no data | |
Senior VP of Engineering & Operations | less than a year | no data | no data | |
Vice President of Corporate Communications | 2.9yrs | no data | no data | |
Vice President of Sales & Marketing | 1.9yrs | no data | no data | |
Corporate Controller | less than a year | no data | no data | |
VP of Finance & Company Secretary | no data | no data | no data |
1.9yrs
Average Tenure
Experienced Management: OBI's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 20.8yrs | CA$892.12k | 39.48% £ 8.5m | |
President | 7.8yrs | CA$1.16m | 1.03% £ 221.0k | |
Senior Independent Non-Executive Director | 3.1yrs | CA$120.58k | 0.075% £ 16.1k | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Chairman of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Chairman of Medical Advisory Board | 6.8yrs | no data | no data | |
Independent Non-Executive Director | less than a year | CA$21.96k | no data | |
Independent Chairman of the Board | 6.9yrs | CA$133.06k | 0.13% £ 27.4k | |
Independent Non-Executive Director | 3.1yrs | CA$110.56k | 0.11% £ 24.6k |
6.8yrs
Average Tenure
64.5yo
Average Age
Experienced Board: OBI's board of directors are considered experienced (6.8 years average tenure).